The auditory and vestibular toxicities induced by antiepileptic drugs

References

• Osuntokun BO. Epilepsy in the African continent. In: Peny JK, editor. Epilepsy: the eighth international symposium PP. New York (NY): Ravan Press; 1977. p. 365–378.
   Google Scholar
• Hauser WA. Incidence and prevalence. In: VNGel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven; 1997. p. 47–57.
   Google Scholar
• Kandil MR, Ahmed WA, Sayed AM, et al. Pattern of epilepsy in childhood and adolescence: a hospital-based study. African J Neurol Sci. 2007;26(1):33–45.
   Google Scholar
• Engel J Jr. Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention. Neurology. 1998;51(5):1243–1244.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Aspects T. Mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neurosci Ther. 2009;15(2):134–156.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Psychiatric symptomatology and disorders related to epilepsy and antiepileptic medications. Expert Opin Drug Saf. 2011;1096:913–934.
   Web of Science ®Google Scholar
• Hamed SA, Metwaly NA, Hassan MM, et al. Depression in adults with epilepsy: relationship to psychobiological variables. World J Neurol. 2012;2(1):1–10.
   Google Scholar
• Hamed SA, Elserogy YE, Abd-ElHafeez HA. Psychopathological and peripheral level of neurobiological correlates of obsessive compulsive symptoms with epilepsy: a hospital-based study. Epilepsy Behav. 2013;27(2):409–415.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Hamed EA, Kandil MR, et al. Hormone balance and lipid profile in patients with epilepsy. Epilepsy Res. 2005;66(1–3):173–183.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Hamed EA, Hamdy R, et al. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 2007;74(2–3):183–192.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Atherosclerosis in epilepsy: its causes and implications. Epilepsy Behav. 2014;41:290–296.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions. Epilepsy Res. 2007;75(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Antiepileptic drugs influences on body weight in people with epilepsy. Expert Rev Clin Pharmacol. 2015;8(1):103–114.
   PubMed Web of Science ®Google Scholar
• Armon C, Brown E, Carwile S, et al. Sensorineural hearing loss: a reversible effect of valproic acid. Neurology. 1990;40(12):1896–1898.
   PubMed Web of Science ®Google Scholar
• Hori A, Kataoka S, Sakai K, et al. Valproic acid-induced hearing loss and tinnitus. Intern Med. 2003;42(11):1153–1154.
   PubMed Web of Science ®Google Scholar
• Yeap LL, Lim KS, Lo YL, et al. Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modelling during a valproate rechallenge. Epileptic Disord. 2014;16(3):375–379.
   PubMed Web of Science ®Google Scholar
• Papadeas E, Polychronopoulos P, Papathanasopoulos P, et al. Sensorineural hearing loss: a reversible effect of vigabatrin. Neurology. 2003;61(7):1020–1021.
   PubMed Web of Science ®Google Scholar
• Pierce DA, Holt SR, Reeves-Daniel A. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. Clin Ther. 2008;30(9):1681–1684.
   PubMed Web of Science ®Google Scholar
• De La Cruz M, Bance M. Carbamazepine-induced sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 1999;125(2):225–227.
   PubMedGoogle Scholar
• Tateno A, Morisawa K, Sawai K, et al. Three cases of partial epilepsy accompanied by hearing disorder during CBZ medication. Shonika Rinsho. 1993;46: 322–326. (Abstract in Japanese).
   Google Scholar
• Chaloupka V, Mitchell S, Muirhead R. Observation of a reversible, medication-induced change in pitch perception. J Acoust Soc Am. 1994;96(1):145–149.
   PubMed Web of Science ®Google Scholar
• Onodera M, Ogino T. A case report on auditory disturbance secondary to carbamazepine. Nihon Jibiinkoka Gakkai Kaihou. 1994;97: 562. (Abstract in Japanese).
   Google Scholar
• Mabuchi K, Hayashi S, Nitta E, et al. Auditory disturbance induced by carbamazepine administration in a patient with secondary generalized seizure. Rinsho Shinkeigaku. 1995;35(5):553–555.
   PubMedGoogle Scholar
• Senjo M. A case of psychogenic reaction whose tone was flattered by carbamazepine. Seishin Igaku. 1995;37: 649–651. (Abstract in Japanese).
   Google Scholar
• Nihei K, Naito H. Two cases of the abnormality of the absolute musical scale recognition by carbamazepine administration. Tenkan Kenkyu. 1997;15: 68–69. (Abstract in Japanese).
   Google Scholar
• Yamamoto M, Wada K, Sakai K, et al. Auditory disturbance induced by carbamazepine. Epilepsia. 1997;38: 132. (Abstract in Japanese).
   Google Scholar
• Kashihara K, Imai K, Shiro Y, et al. Reversible pitch perception deficit due to carbamazepine. Intern Med. 1998;37(9):774–775. .
   PubMed Web of Science ®Google Scholar
• Tsuji S, Horiguti J, Yamashita H, et al. A case of the manic depressive psychosis presenting whole tone lowering of the perception sound in the administration of carbamazepine. Seishin Igaku. 1998;40: 1213–1215. (Abstract in Japanese).
   Google Scholar
• Emori K, Uehara T, Murata M, et al. A case of the complex partial seizure which produced semitone lowering of the reversible perception sound in a blood concentration rise of carbamazepine. 33rd Nihon Tenkan Gakkai. 1999;174 ( (Abstract in Japanese)).
   Google Scholar
• Miyaoka T, Seno H, Itoga M, et al. Reversible pitch perception deficit caused by carbamazepine. Clin Neuropharmacol. 2000;23(4):219–221.
   PubMed Web of Science ®Google Scholar
• Tateno A, Omura I. Two cases of auditory disturbance caused by carbamazepine. No To Hattatsu. 2000;32(5):420–423.
   PubMedGoogle Scholar
• Watanabe T, Minagawa K, Nihira H, et al. Two cases of auditory disturbance due to carbamazepine. Tenkan Nituite. 2000;20: 39–44. (Abstract in Japanese).
   Google Scholar
• Kobayashi T, Nisijima K, Ehara Y, et al. Pitch perception shift: a rare side-effect of carbamazepine. Psychiatry Clin Neurosci. 2001;55(4):415–417.
   PubMed Web of Science ®Google Scholar
• Konno S, Yamazaki E, Kudoh M, et al. Half pitch lower sound perception caused by carbamazepine. Intern Med. 2003;42(9):880–883. .
   PubMed Web of Science ®Google Scholar
• Yoshikawa H, Abe T. Carbamazepine-induced abnormal pitch perception. Brain Dev. 2003;25(2):127–129.
   PubMed Web of Science ®Google Scholar
• Fujimoto A, Enomoto T, Takano S, et al. Pitch perception abnormality as a side effect of carbamazepine. J Clin Neurosci. 2004;11(1):69–70.
   PubMed Web of Science ®Google Scholar
• Wakamoto H, Kume A, Nakano N. Elevated pitch perception owing to carbamazepine-activating effect on the peripheral auditory system: auditory brainstem response study. J Child Neurol. 2004;19(6):453–455.
   PubMed Web of Science ®Google Scholar
• Braun M, Chaloupka V. Carbamazepine induced pitch shift and octave space representation. Hear Res. 2005;210(1–2):85–92.
   PubMed Web of Science ®Google Scholar
• Tateno A, Sawada K, Takahashi I, et al. Carbamazepine-induced transient auditory pitch-perception deficit. Pediatr Neurol. 2006;35(2):131–134.
   PubMed Web of Science ®Google Scholar
• Gur-Ozmen S, Nirmalananthan N, Von Oertzen TJ. Change of pitch due to carbamazepine and oxcarbazepine independently. Seizure. 2013;22(2):162–163.
   PubMed Web of Science ®Google Scholar
• Rodin E, Chayasirisobhon S, Klutke G. Brainstem auditory evoked potential recording in patients with epilepsy. Clin Electroencephalogr. 1982;13(3):154–161.
   PubMedGoogle Scholar
• Mervaala E, Keränen T, Tiihonen P, et al. The effects of carbamazepine and sodium valproate on SEPs and BAEPs. Electroencephalogr Clin Neurophysiol. 1987;68(6):475–478.
   PubMedGoogle Scholar
• Medaglini S, Filippi M, Smirne S, et al. Effects of long-lasting antiepileptic therapy on brainstem auditory evoked potentials. Neuropsychobiology. 1988;19(2):104–107.
   PubMed Web of Science ®Google Scholar
• Drake ME Jr, Pakalnis A, H P, et al. Effect of anti-epileptic drug monotherapy and polypharmacy on visual and auditory evoked potentials. Electromyogr Clin Neurophysiol. 1989;29(1):55–58.
   PubMedGoogle Scholar
• van Wieringen A, Binnie CD, Meijer JW, et al. Comparison of the effects of lamotrigine and phenytoin on the EEG power spectrum and cortical and brainstem-evoked responses of normal human volunteers. Neuropsychobiology. 1989;21(3):157–169.
   PubMed Web of Science ®Google Scholar
• Japaridze G, Kvernadze D, Geladze T, et al. Effects of carbamazepine on auditory brainstem response, middle-latency response, and slow cortical potential in epileptic patients. Epilepsia. 1993;34(6):1105–1109.
   PubMed Web of Science ®Google Scholar
• Yuksel A, Senocak D, Sozuer D, et al. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. Childs Nerv Syst. 1995;11(8):474–477.
   PubMed Web of Science ®Google Scholar
• Panjwani U, Singh SH, Sel Vamurthy W, et al. Brainstem auditory evoked potentials in epileptics on different anti-epileptic drugs. Indian J Physiol Pharmacol. 1996;40(1):29–34.
   PubMedGoogle Scholar
• Rysz A, Gajkowski K. Effect of phenytoin and carbamazepine on evoked potentials in patients with newly diagnosed epilepsy. Part II. Brainstem auditory evoked potentials. Neurol Neurochir Pol. 1996;30(6):971–979.
   PubMedGoogle Scholar
• Verrotti A, Trotta D, Cutarella R, et al. Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol. 2000;23(5):397–402. .
   PubMed Web of Science ®Google Scholar
• Zgorzalewicz M. Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy. Neurol Neurochir Pol. 2000;34(Suppl 1):119–218.
   PubMedGoogle Scholar
• Poblano A, Belmont A, Sosa J, et al. Effects of prenatal exposure to carbamazepine on brainstem auditory evoked potentials in infants of epileptic mothers. J Child Neurol. 2002;17(5):364–368.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Darwish ES, Youssef AH, et al. The effect of antiepileptic drugs on the evoked potentials of children with idiopathic epilepsy. J Pediatric Epilepsy. 2012;2:103–112. .
   Google Scholar
• Hirose G, Chujo T, Kataoka S, et al. Acute effects of anticonvulsants on brain-stem auditory evoked potentials in rats. Electroencephalogr Clin Neurophysiol. 1990;75(6):543–547.
   PubMedGoogle Scholar
• Sitges M, Nekrassov V. Acute and chronic effects of carbamazepine, phenytoin, valproate and vinpocetine on BAEP parameters and threshold in the guinea pig. Clin Neurophysiol. 2007;118(2):420–426.
   PubMed Web of Science ®Google Scholar
• Dubiel A, Kulesza RJ Jr. Prenatal valproic acid exposure disrupts tonotopic c-Fos expression in the rat brainstem. Neuroscience. 2016;324:511–523.
   PubMed Web of Science ®Google Scholar
• Umeda Y, Sakata E. Equilibrium disorder in carbamazepine toxicity. Ann Otol Rhinol Laryngol. 1977;86(3 Pt 1):318–322.
   PubMed Web of Science ®Google Scholar
• Pellock JM. Carbamazepine side effects in children and adults. Epilepsia. 1987;28(Suppl 3):S64–S70.
   PubMed Web of Science ®Google Scholar
• Rösel T, Schneider J, Fischer JT, et al. Carbamazepine poisoning caused by confusing the drugs. Dtsch Med Wochenschr. 2000;125(12):352–356.
   PubMed Web of Science ®Google Scholar
• De Diego JI, Prim MP, Marcos S, et al. Vestibular and hearing manifestations of phenytoin toxicity: a retrospective series. Ear Nose Throat J. 2001;80(6):404, 407–409.
   Google Scholar
• Fife TD, Blum D, Fisher RS. Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res. 2006;70(2–3):103–109.
   PubMed Web of Science ®Google Scholar
• Chimirri S, Aiello R, Mazzitello C, et al. Vertigo/dizziness as a Drugs’ adverse reaction. J Pharmacol Pharmacother. 2013;4(Suppl 1):S104–S109.
   PubMedGoogle Scholar
• Hamed SA, Tohamy AM, Oseilly AM. Vestibular function in adults with epilepsy of unknown etiology. Otol Neurotol. 2017;38(8):1217–1224.
   PubMed Web of Science ®Google Scholar
• Gao XM, Margolis RL, Leeds P, et al. Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-D-aspartate, aurintricarboxylic acid and cycloheximide. Brain Res. 1995;703(1–2):63–71.
   PubMed Web of Science ®Google Scholar
• Saunders PA, Ishitani R, Leeds P, et al. Comparison of carbamazepine, phenytoin, and age-induced cell death in cerebellar granule cells. Soc Neurosci Abstr. 1995;21:1553.
   Google Scholar
• Yan GM, Irwin RP, Lin SZ, et al. Diphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons. J Pharmacol Exp Ther. 1995;274(2):983–990.
   PubMed Web of Science ®Google Scholar
• Nonaka S, Katsube N, Chuang DM. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther. 1998;286(1):539–547.
   PubMed Web of Science ®Google Scholar
• Macdonald RL, McLean MJ, Skerritt JH. Anticonvulsant drug mechanisms of action. Fed Proc. 1985;44(10):2634–2639.
   PubMedGoogle Scholar
• Mulleners WM, Chronicle EP, Vredeveld JW, et al. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol. 2002;9(1):35–40.
   PubMed Web of Science ®Google Scholar
• Kazis DA, Kimiskidis VK, Papagiannopoulos S, et al. The effect of valproate on silent period and corticomotor excitability. Epileptic Disord. 2006;8(2):136–142.
   PubMed Web of Science ®Google Scholar
• Hamed SA. A migraine variant with abdominal colic and Alice in Wonderland syndrome: a case report and review. BMC Neurol. 2010;10(1):2.
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Carbamazepine-mechanisms of action. In: Levy R, Mattson R, Meldrum B, et al., editors. Antiepileptic drugs. 3rd ed. New York (NY): Raven Press, Ltd; 1989. p. 447–455.
   Google Scholar
• Nekrassov V, Sitges M. Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci Lett. 2006;406(3):276–280.
   PubMed Web of Science ®Google Scholar
• Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston (MA): Little Brown and Co; 1954.
   Google Scholar
• Berkovic SF, McIntosh A, Howell RA, et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol. 1996;40(2):227–235.
   PubMed Web of Science ®Google Scholar
• Boatman DF, Lesser RP, Crone NE, et al. Speech recognition impairments in patients with intractable right temporal lobe epilepsy. Epilepsia. 2006;47(8):1397–1401.
   PubMed Web of Science ®Google Scholar
• Miyajima M, Ohta K, Hara K, et al. Abnormal mismatch negativity for pure-tone sounds in temporal lobe epilepsy. Epilepsy Res. 2011;94(3):149–157.
   PubMed Web of Science ®Google Scholar
• Lavasani AN, Mohammadkhani G, Motamedi M, et al. Auditory temporal processing in patients with temporal lobe epilepsy. Epilepsy Behav. 2016;60:81–85.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Q, You Y, et al. The role of the temporal pole in modulating primitive auditory memory. Neurosci Lett. 2016;619:196–202.
   PubMed Web of Science ®Google Scholar
• Sanchex Longo LP, Forster FM, Auth TL. A clinical test for sound localization and its applications. Neurology. 1957;7(9):655–663.
   PubMed Web of Science ®Google Scholar
• Luria AR. The functional organization of the brain. Sci Am. 1970;222(3):66–72.
   PubMed Web of Science ®Google Scholar
• Musiek FE. Frequency (pitch) and duration pattern tests. J Am Acad Audiol. 1994;5(4):265–268.
   PubMedGoogle Scholar
• Bellis TJ. Interpretation of central auditory assessment results. In: Bellis TJ, editor. Assessment and management of central auditory processing disorders in the educational setting: from science to practice. San Diego (CA): Singular Publishing Group; 1996. p. 349.
   Google Scholar
• Bougeard R, Fischer C. The role of the temporal pole in auditory processing. Epileptic Disord. 2002 Sep;4(Suppl 1):S29–S32.
   PubMed Web of Science ®Google Scholar
• Soliman S, Mostafa M, Kamal N, et al. Auditory evoked potentials in epileptic patients. Ear Hear. 1993;14(4):235–241.
   PubMed Web of Science ®Google Scholar
• Kogeorgos J, Scott DF, Swash M. Epileptic dizziness. Br Med J (Clin Res Ed). 1981;282(6265):687–689.
   PubMed Web of Science ®Google Scholar
• Kluge M, Beyenburg S, Fernández G, et al. Epileptic vertigo: evidence for vestibular representation in human frontal cortex. Neurology. 2000;55(12):1906–1908.
   PubMed Web of Science ®Google Scholar
• Kahane P, Hoffmann D, Minotti L, et al. Reappraisal of the human vestibular cortex by cortical electrical stimulation study. Ann Neurol. 2003;54(5):615–624.
   PubMed Web of Science ®Google Scholar
• Laff R, Mesad S, Devinsky O. Epileptic kinetopsia: ictal illusory motion perception. Neurology. 2003;61(9):1262–1264.
   PubMed Web of Science ®Google Scholar
• Isnard J, Guénot M, Sindou M, et al. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia. 2004;45(9):1079–1090.
   PubMed Web of Science ®Google Scholar
• Hewett R, Guye M, Gavaret M, et al. Benign temporo-parieto-occipital junction epilepsy with vestibular disturbance: an underrecognized form of epilepsy? Epilepsy Behav. 2011;21(4):412–416. .
   PubMed Web of Science ®Google Scholar
• Lopez C, Heydrich L, Seeck M, et al. Abnormal self-location and vestibular vertigo in a patient with right frontal lobe epilepsy. Epilepsy Behav. 2010;17(2):289–292.
   PubMed Web of Science ®Google Scholar
• Tarnutzer AA, Lee SH, Robinson KA, et al. Clinical and electrographic findings in epileptic vertigo and dizziness. A systemic review. Neurology. 2015;84(15):1595–1604.
   PubMed Web of Science ®Google Scholar
• Bladin PF. History of “epileptic vertigo”: its medical, social, and forensic problems. Epilepsia. 1998;39(4):442–447.
   PubMed Web of Science ®Google Scholar
• Berkovic SF, Crompton DE. The borderland of epilepsy: a clinical and molecular view, 100 years on. Epilepsia. 2010;51(Suppl 1):3–4.
   PubMed Web of Science ®Google Scholar
• Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain. 2008;131(Pt 10):2538–2552.
   PubMed Web of Science ®Google Scholar
• Li L, Wang NY, Zhang H, et al. Primary investigation of central auditory function in patients with temporal lobe epilepsy. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007;42(9):664–668.
   PubMedGoogle Scholar
• Beitinger PA, Kirmeier T, Bronisch T, et al. Association of auditory hallucinations and anticonvulsant hypersensitivity syndrome with carbamazepine treatment. A case report. Pharmacopsychiatry. 2006;39(5):192–193.
   PubMed Web of Science ®Google Scholar
• Incecik F, Akoglu E, Sangün O, et al. Effects of valproic acid on hearing in epileptic patients. Int J Pediatr Otorhinolaryngol. 2007;71(4):611–614.
   PubMed Web of Science ®Google Scholar
• Fukai M, Motomura N, Kobayashi S, et al. Event-related potential (P300) in epilepsy. Acta Neurol Scand. 1990;82(3):197–202.
   PubMed Web of Science ®Google Scholar
• Rowe MJ 3rd. Normal variability of the brain-stem auditory evoked response in young and old adult subjects. Electroencephalogr Clin Neurophysiol. 1978;44(4):459–470.
   PubMedGoogle Scholar
• Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol. 1998;15(1):14–33.
   PubMed Web of Science ®Google Scholar
• Brinciotti M. Effects of chronic high serum levels of phenobarbital on evoked potentials in epileptic children. Electroencephalogr Clin Neurophysiol. 1994;92(1):11–16.
   PubMedGoogle Scholar
• Kubota F, Ohnishi N, Nakajima M, et al. Effects of zonisamide on BAEP, SSEP and P300. Clin Electroencephalogr. 1995;26(2):120–123.
   PubMedGoogle Scholar
• Alfaro-Rodríguez A, Vargas-Sánchez J, Bandala C, et al. Carbamazepine produces changes in the auditory pathway of Wistar rats. Rev Invest Clin. 2014;66(4):345–350.
   PubMedGoogle Scholar
• Spoendlin H. The innervation of the cochlear receptor. In: Møller AR, editor. Basic mechanisms in hearing. Newyork, NY: Academic Press; 1973. p. 185–234.
   Google Scholar
• Liberman MC, Dodds LW, Pierce S. Afferent and efferent innervation of the cochlea: quantitative analysis with light and electron microscopy. J Comp Neurol. 1990;301(3):443–460.
   PubMed Web of Science ®Google Scholar
• Wedemeyer C, Zorrilla de San Martín J, Ballestero J, et al. Activation of presynaptic GABAB(1a,2) receptors inhibits synaptic transmission at mammalian inhibitory cholinergic olivocochlear-hair cell synapses. J Neurosci. 2013;33(39):15477–15487.
   PubMed Web of Science ®Google Scholar
• Boiko T, Rasband MN, Levinson SR, et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron. 2001;30(1):91–104.
   PubMed Web of Science ®Google Scholar
• Dib-Hajj S, Black JA, Cummins TR, et al. NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci. 2002;25(5):253–259.
   PubMed Web of Science ®Google Scholar
• Vayer P, Cash CD, Maitre M. Is the anticonvulsant mechanism of valproate linked to its interaction with the cerebral gamma-hydroxybutyrate system? Trends Pharmacol Sci. 1988;9(4):127–129.
   PubMed Web of Science ®Google Scholar
• Gean PW, Huang CC, Hung CR, et al. Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices. Brain Res Bull. 1994;33(3):333–336.
   PubMed Web of Science ®Google Scholar
• Errington AC, Sto¨Hr T, Heers C, et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73(1):157–169.
   PubMed Web of Science ®Google Scholar
• Myslobodsky MS, Morag M. Pharmacologic analysis of sodium valproate-induced suppression of secondary components of visual evoked potentials in albino rats. Pharmacol Biochem Behav. 1981;15(5):681–685.
   PubMed Web of Science ®Google Scholar
• Löscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol. 1999;58(1):31–59.
   PubMed Web of Science ®Google Scholar
• Greferath U, Müller F, Wässle H, et al. Localization of GABAA receptors in the rat retina. Vis Neurosci. 1993;10(3):551–561.
   PubMed Web of Science ®Google Scholar
• Frumkes TE, Miller RF, Slaughter M, et al. Physiological and pharmacological basis of GABA and glycine action on neurons of mudpuppy retina. III. Amacrine-mediated inhibitory influences on ganglion cell receptive-field organization: a model. J Neurophysiol. 1981;45(4):783–804.
   PubMed Web of Science ®Google Scholar
• Wada Y, Okuda H, Hasegawa H, et al. Acute effects of sodium valproate on epileptic photosensitivity in the lateral geniculate-kindled cat. Jpn J Psychiatry Neurol. 1988;42(2):351–356.
   PubMedGoogle Scholar
• Suter S, Armstrong CA, Suter PS, et al. Spatial-frequency-tuned attenuation and enhancement of the steady-state VEP by grating adaptation. Vision Res. 1991;31(7–8):1167–1175.
   PubMed Web of Science ®Google Scholar
• Connors BW. GABA A- and GABA B-mediated processes in visual cortex. In: Mize RR, Marc RE, Sillito AM, editors. GABA in the retina and central visual system. Amsterdam: Elsevier Science Publishers; 1992. p. 335–348.
   Google Scholar
• Groner M, Fisch HU, Walder F, et al. Specific effects of the benzodiazepine midazolam on visual receptive fields in light and dark adapted human subjects. Psychopharmacology (Berl). 1992;109(1–2):68–76.
   PubMed Web of Science ®Google Scholar
• Vidyasagar TR, Mueller A. Function of GABAA inhibition in specifying spatial frequency and orientation selectivities in cat striate cortex. Exp Brain Res. 1994;98(1):31–38.
   PubMed Web of Science ®Google Scholar
• Berman NJ, Douglas RJ, Martin KAC. GABA-mediated inhibition in the neural networks of visual cortex. In: Mize RR, Marc RE, Sillito AM, editors. GABA in the retina and central visual system. Amsterdam: Elsevier Science Publishers; 1992. p. 443–476.
   Google Scholar
• Ozkul Y, Gurler B, Uckardes A, et al. Visual functions in epilepsy patients on valproate monotherapy. J Clin Neurosci. 2002;9(3):247–250.
   PubMed Web of Science ®Google Scholar
• Hudnell HK, Boyes WK The comparability of rat and human visual-evoked potentials. Neurosci Biobehav Rev. Spring 1991;15(1):159–164.
   PubMed Web of Science ®Google Scholar
• Zemon V, Kaplan E, Ratliff F. Bicuculline enhances a negative component and diminishes a positive component of the visual evoked cortical potential in the cat. Proc Natl Acad Sci U S A. 1980;77(12):7476–7478.
   PubMed Web of Science ®Google Scholar
• Marciani MG, Spanedda F, Mattia D. Neurophysiologic and neuropsychologic profiles of lamotrigine in epilepsy. Clin Neuropharmacol. 1999;22(3):159–163.
   PubMed Web of Science ®Google Scholar
• Fitton A, Goa KL. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Drugs. 1995;50(4):691–713.
   PubMed Web of Science ®Google Scholar
• Bisht M, Bist SS. Ototoxicity: the hidden menace. Indian J Otolaryngol Head Neck Surg. 2011;63(3):255–259.
   PubMed Web of Science ®Google Scholar
• Palomar García V, Abdulghani Martínez F, Bodet Agustí E, et al. Drug-induced otoxicity: current status. Acta Otolaryngol. 2001;121(5):569–572.
   PubMed Web of Science ®Google Scholar
• Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngol Head Neck Surg. 2014;151(4):533–541.
   PubMed Web of Science ®Google Scholar
• American Speech-Language-Hearing Association (ASHA). 1997. Guidelines for Audiologic Screening. Available from: http://www.asha.org/policy/GL1997-00199/ doi:10.1044/policy.GL1997-00199
   Google Scholar
• Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11(6):430–433.
   PubMed Web of Science ®Google Scholar
• Barton MB, Miller T, Wolff T, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–127.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Haridi MA, Ali AM, et al. Peripheral and central auditory pathways function in patients with type 2 diabetes mellitus. J Neurol Neurosci. 2014;5(1):2.
   Google Scholar
• Lin CF, Lee KJ, Yu SS, et al. Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss. Laryngoscope. 2016;126(1):142–149.
   PubMed Web of Science ®Google Scholar
• Gelfand SA. Acoustic reflex threshold tenth percentiles and functional hearing impairment. J Am Acad Audiol. 1994;5(1):10–16.
   PubMedGoogle Scholar
• Lightfoot GR. ABR screening for acoustic neuromata: the role of rate-induced latency shift measurements. Br J Audiol. 1992;26(4):217–227.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Komatsuzaki A, Hentona H. Usefulness of auditory brainstem responses at high stimulus rates in the diagnosis of acoustic neuroma. ORL J Otorhinolaryngol Relat Spec. 1996;58(4):224–228.
   PubMed Web of Science ®Google Scholar
• Burkard RF, Sims D. The human auditory brainstem response to high click rates: aging effects. Am J Audiol. 2001;10(2):53–61.
   PubMedGoogle Scholar
• Sha SH, Taylor R, Forge A, et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001;155(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Namysłowski G, Trybalska G, Scierski W, et al. Hearing evaluation in patients suffering from hypercholesterolemia]. Otolaryngol Pol. 2003;57(5):725–730.
   PubMedGoogle Scholar
• Hamed SA, Elattar AM. Auditory involvement in hyperuricemia: otoacoustic emissions analysis. Am J Otolaryn. 2010;31(3):154–161.
   Google Scholar
• Lisowska G, Namysłowski G, Morawski K, et al. Otoacoustic emissions and auditory brain stem responses in insulin dependent diabetic patients. Otolaryngol Pol. 2002;56(2):217–225.
   PubMedGoogle Scholar
• Probst R, Harris FP. Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears. Arch Otolaryngol Head Neck Surg. 1993;119(8):858–860.
   PubMedGoogle Scholar
• Kemp DT. Otoacoustic emissions, traveling waves and cochlear mechanisms. Hear Res. 1986;22:95–104.
   PubMed Web of Science ®Google Scholar
• Ganança MM, Caovilla HH, Ganança FF. Electronystagmography versus videonystagmography. Braz J Otorhinolaryngol. 2010;76(3):399–403.
   PubMed Web of Science ®Google Scholar
• Yueh B, Collins MP, Souza PE, et al. Screening for auditory impairment-which hearing assessment test (SAI-WHAT): RCT design and baseline characteristics. Contemp Clin Trials. 2007;28(3):303–315.
   PubMed Web of Science ®Google Scholar
• Mulrow CD, Aguilar C, Endicott JE, et al. Quality-of-life changes and hearing impairment. A randomized trial. Ann Intern Med. 1990;113(3):188–194.
   PubMed Web of Science ®Google Scholar